{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:09:57Z","timestamp":1778497797828,"version":"3.51.4"},"reference-count":97,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.retram.2025.103513","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:12:47Z","timestamp":1744477967000},"page":"103513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Therapeutic promise of CRISPR-Cas9 gene editing in sickle cell disease and \u03b2-thalassemia: A current review"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6722-6667","authenticated-orcid":false,"given":"Hassan H.","family":"Almasoudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.retram.2025.103513_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/frhem.2024.1468952","article-title":"Recent advancements in gene therapy for sickle cell disease and \u03b2-thalassemia","volume":"3","author":"Li","year":"2024","journal-title":"Front Hematol"},{"key":"10.1016\/j.retram.2025.103513_bib0002","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.ymthe.2024.03.005","article-title":"Autologous gene therapy for hemoglobinopathies: from bench to patient's bedside","volume":"32","author":"Locatelli","year":"2024","journal-title":"Mol Ther"},{"key":"10.1016\/j.retram.2025.103513_bib0003","first-page":"251","article-title":"Physiology of haemoglobin","volume":"12","author":"Thomas","year":"2012","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"10.1016\/j.retram.2025.103513_bib0004","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMcibr1809628","article-title":"Hemoglobinopathies in the fetal position","volume":"379","author":"Pasricha","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.retram.2025.103513_bib0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMra2021838","article-title":"\u03b2-Thalassemias","volume":"384","author":"Taher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.retram.2025.103513_bib0006","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell Disease: a review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.retram.2025.103513_bib0007","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.944204","article-title":"Editorial: first regulatory approvals for CRISPR-Cas9 therapeutic gene editing for Sickle cell disease and transfusion-dependent \u03b2-thalassemia","volume":"30","author":"Parums","year":"2024","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.retram.2025.103513_bib0008","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1073\/pnas.1612075113","article-title":"Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: an approach for treating sickle cell disease and \u03b2-thalassemia","volume":"113","author":"Ye","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.retram.2025.103513_bib0009","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40291-024-00696-z","article-title":"Exagamglogene Autotemcel: first approval","volume":"28","author":"Hoy","year":"2024","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.retram.2025.103513_bib0010","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.retram.2025.103513_bib0011","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3885979","article-title":"Sickle cell Disease in children and adolescents: a review of the historical, clinical, and public health perspective of Sub-Saharan Africa and beyond","volume":"2022","author":"Egesa","year":"2022","journal-title":"Int J Pediatr"},{"key":"10.1016\/j.retram.2025.103513_bib0012","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-7299-9_2","article-title":"Genetic basis and Genetic modifiers of \u03b2-thalassemia and sickle cell disease","volume":"1013","author":"Thein","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.retram.2025.103513_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2024.101185","article-title":"Revolutionising healing: gene Editing's breakthrough against sickle cell disease","volume":"65","author":"Dimitrievska","year":"2024","journal-title":"Blood Rev"},{"key":"10.1016\/j.retram.2025.103513_bib0014","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011700","article-title":"The molecular basis of \u03b2-thalassemia","volume":"3","author":"Thein","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.retram.2025.103513_bib0015","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/S0140-6736(22)00536-0","article-title":"Thalassaemia","volume":"399","author":"Kattamis","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.retram.2025.103513_bib0016","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.retram.2025.103513_bib0017","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrmicro3279","article-title":"Unravelling the structural and mechanistic basis of CRISPR\u2013Cas systems","volume":"12","author":"Van Der Oost","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.retram.2025.103513_bib0018","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00471","article-title":"RNA-programmed genome editing in human cells","volume":"2","author":"Jinek","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.retram.2025.103513_bib0019","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.retram.2025.103513_bib0020","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature09886","article-title":"CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III","volume":"471","author":"Deltcheva","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.retram.2025.103513_bib0021","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.retram.2025.103513_bib0022","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.retram.2025.103513_bib0023","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.retram.2025.103513_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147480","article-title":"CRISPR\/Cas9-based gene-editing technology for sickle cell disease","volume":"874","author":"Ma","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.retram.2025.103513_bib0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biochi.2015.03.025","article-title":"The CRISPR-Cas immune system: biology, mechanisms and applications","volume":"117","author":"Rath","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.retram.2025.103513_bib0026","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-4939-2687-9_4","article-title":"Annotation and classification of CRISPR-Cas systems","volume":"1311","author":"Makarova","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.retram.2025.103513_bib0027","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/acschembio.7b00855","article-title":"Type II-C CRISPR-Cas9 biology, mechanism, and application","volume":"13","author":"Mir","year":"2018","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.retram.2025.103513_bib0028","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.molcel.2016.02.018","article-title":"Structural basis for the altered PAM specificities of engineered CRISPR-Cas9","volume":"61","author":"Hirano","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.retram.2025.103513_bib0029","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.omtn.2017.02.006","article-title":"Optimizing the DNA donor template for homology-directed repair of double-strand breaks","volume":"7","author":"Song","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.retram.2025.103513_bib0030","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR\u2013Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.retram.2025.103513_bib0031","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04766","article-title":"Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery","volume":"3","author":"Lin","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.retram.2025.103513_bib0032","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.stem.2019.08.016","article-title":"NHEJ-mediated repair of CRISPR-Cas9-induced DNA breaks efficiently corrects mutations in HSPCs from patients with Fanconi anemia","volume":"25","author":"Rom\u00e1n-Rodr\u00edguez","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.retram.2025.103513_bib0033","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/febs.13586","article-title":"Potential pitfalls of CRISPR\/Cas9-mediated genome editing","volume":"283","author":"Peng","year":"2016","journal-title":"FEBS J"},{"key":"10.1016\/j.retram.2025.103513_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsyr\/fov004","article-title":"CRISPR\/Cas9: a molecular swiss army knife for simultaneous introduction of multiple genetic modifications in Saccharomyces cerevisiae","volume":"15","author":"Mans","year":"2015","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.retram.2025.103513_bib0035","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res"},{"key":"10.1016\/j.retram.2025.103513_bib0036","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1074-7613(01)00144-3","article-title":"Toll meets bacterial CpG-DNA","volume":"14","author":"Wagner","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.retram.2025.103513_bib0037","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nmeth.2030","article-title":"Targeted gene knockout by direct delivery of zinc-finger nuclease proteins","volume":"9","author":"Gaj","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.retram.2025.103513_bib0038","article-title":"Efficient delivery of CRISPR-Cas9 for genome editing via self-assembled DNA nanoclews","volume":"54","author":"Sun","year":"2015","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.retram.2025.103513_bib0039","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.3081","article-title":"Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo","volume":"33","author":"Zuris","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.retram.2025.103513_bib0040","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gr.171264.113","article-title":"Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA","volume":"24","author":"Ramakrishna","year":"2014","journal-title":"Genome Res"},{"key":"10.1016\/j.retram.2025.103513_bib0041","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1101\/gr.163394.113","article-title":"Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases","volume":"24","author":"Sung","year":"2014","journal-title":"Genome Res"},{"key":"10.1016\/j.retram.2025.103513_bib0042","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nbt.3055","article-title":"In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9","volume":"33","author":"Swiech","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.retram.2025.103513_bib0043","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nmeth.3075","article-title":"Adenoviral vector DNA for accurate genome editing with engineered nucleases","volume":"11","author":"Holkers","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.retram.2025.103513_bib0044","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nbt.3127","article-title":"Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors","volume":"33","author":"Wang","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.retram.2025.103513_bib0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nbt.2800","article-title":"Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library","volume":"32","author":"Koike-Yusa","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.retram.2025.103513_bib0046","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1261\/rna.051631.115","article-title":"Expression of CRISPR\/Cas single guide RNAs using small tRNA promoters","volume":"21","author":"Mefferd","year":"2015","journal-title":"RNA"},{"key":"10.1016\/j.retram.2025.103513_bib0047","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.retram.2025.103513_bib0048","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tibtech.2017.11.006","article-title":"Engineering the delivery system for CRISPR-based genome editing","volume":"36","author":"Glass","year":"2018","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.retram.2025.103513_bib0049","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1182\/blood-2012-06-292078","article-title":"Reawakening fetal hemoglobin: prospects for new therapies for the \u03b2-globin disorders","volume":"120","author":"Bauer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103513_bib0050","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1182\/blood.2021014205","article-title":"Disrupting the adult globin promoter alleviates promoter competition and reactivates fetal globin gene expression","volume":"139","author":"Topfer","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103513_bib0051","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41588-018-0085-0","article-title":"Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding","volume":"50","author":"Martyn","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.retram.2025.103513_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103060","article-title":"CRISPR\/Cas9 gene editing for curing sickle cell disease","volume":"60","author":"Park","year":"2021","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.retram.2025.103513_bib0053","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ymthe.2019.05.014","article-title":"Editing the Sickle Cell disease mutation in Human hematopoietic stem cells: comparison of endonucleases and homologous donor templates","volume":"27","author":"Romero","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.retram.2025.103513_bib0054","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 beta-globin gene targeting in Human hematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.retram.2025.103513_bib0055","doi-asserted-by":"crossref","first-page":"7955","DOI":"10.1093\/nar\/gkz475","article-title":"Highly efficient editing of the \u03b2-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease","volume":"47","author":"Park","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.retram.2025.103513_bib0056","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm.4170","article-title":"A genome-editing strategy to treat \u03b2-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition","volume":"22","author":"Traxler","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.retram.2025.103513_bib0057","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/bloodadvances.2019000820","article-title":"Genome editing of HBG1 and HBG2 to induce fetal hemoglobin","volume":"3","author":"M\u00e9tais","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.retram.2025.103513_bib0058","doi-asserted-by":"crossref","first-page":"eaaw3768","DOI":"10.1126\/scitranslmed.aaw3768","article-title":"Therapeutically relevant engraftment of a CRISPR\/Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates","volume":"11","author":"Humbert","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.retram.2025.103513_bib0059","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-4939-7299-9_7","article-title":"Reactivation of fetal hemoglobin for treating \u03b2-thalassemia and sickle cell disease","volume":"1013","author":"Cui","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.retram.2025.103513_bib0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cell.2018.03.016","article-title":"Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.retram.2025.103513_bib0061","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nature15521","article-title":"BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis","volume":"527","author":"Canver","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.retram.2025.103513_bib0062","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejphar.2019.04.042","article-title":"Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: a promising approach for gene therapy of beta thalassemia disease","volume":"854","author":"Khosravi","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.retram.2025.103513_bib0063","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/thalassrep13010006","article-title":"CRISPR gene therapy: a promising one-time therapeutic approach for transfusion-dependent \u03b2-thalassemia\u2014CRISPR-Cas9 gene editing for \u03b2-thalassemia","volume":"13","author":"Gamage","year":"2023","journal-title":"Thalass. Rep."},{"key":"10.1016\/j.retram.2025.103513_bib0064","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jmedgenet-2014-102968","article-title":"CRISPR-Cas9: a new and promising player in gene therapy","volume":"52","author":"Xiao-Jie","year":"2015","journal-title":"J Med Genet"},{"key":"10.1016\/j.retram.2025.103513_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood-2020-139575","article-title":"Safety and efficacy of CTX001 in patients with transfusion-dependent \u03b2-thalassemia and Sickle cell disease: early results from the climb THAL-111 and climb SCD-121 studies of autologous CRISPR-CAS9-modified CD34+ hematopoietic stem and progenitor cells","volume":"136","author":"Frangoul","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103513_bib0066","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood-2021-152892","article-title":"Cedar trial in progress: a first in Human, phase 1\/2 study of the correction of a single nucleotide mutation in autologous HSCs (GPH101) to convert HbS to HbA for treating severe SCD","volume":"138","author":"Kanter","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103513_bib0067","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3892\/br.2020.1355","article-title":"Novel genetic therapeutic approaches for modulating the severity of \u03b2-thalassemia (Review)","volume":"13","author":"Amjad","year":"2020","journal-title":"Biomed Rep"},{"key":"10.1016\/j.retram.2025.103513_bib0068","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","article-title":"Beta-thalassemia","volume":"12","author":"Cao","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.retram.2025.103513_bib0069","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1101\/gr.173427.114","article-title":"Seamless gene correction of \u03b2-thalassemia mutations in patient-specific iPSCs using CRISPR\/Cas9 and piggyBac","volume":"24","author":"Xie","year":"2014","journal-title":"Genome Res"},{"key":"10.1016\/j.retram.2025.103513_bib0070","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/scd.2014.0347","article-title":"Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR\/Cas9 system","volume":"24","author":"Song","year":"2015","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.retram.2025.103513_bib0071","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5966\/sctm.2015-0157","article-title":"Na\u00efve induced pluripotent stem cells generated from \u03b2-thalassemia fibroblasts allow efficient gene correction with CRISPR\/Cas9","volume":"5","author":"Yang","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.retram.2025.103513_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00438-022-01978-z","article-title":"CRISPR\/Cas9, a promising approach for the treatment of \u03b2-thalassemia: a systematic review","volume":"298","author":"Khiabani","year":"2023","journal-title":"Mol Genet Genom"},{"key":"10.1016\/j.retram.2025.103513_bib0073","doi-asserted-by":"crossref","first-page":"16576","DOI":"10.1074\/jbc.M116.719237","article-title":"Combining single strand oligodeoxynucleotides and CRISPR\/Cas9 to correct gene mutations in \u03b2-thalassemia-induced pluripotent stem sells","volume":"291","author":"Niu","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.retram.2025.103513_bib0074","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjh.17167","article-title":"Induction of therapeutic levels of HbF in genome-edited primary \u03b2039-thalassaemia haematopoietic stem and progenitor cells","volume":"192","author":"Mingoia","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2025.103513_bib0075","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1182\/blood-2018-07-863951","article-title":"A natural regulatory mutation in the proximal promoter elevates fetal globin expression by creating a de novo GATA1 site","volume":"133","author":"Martyn","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103513_bib0076","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood.2020006425","article-title":"A natural DNMT1 mutation elevates the fetal hemoglobin level via epigenetic derepression of the \u03b3-globin gene in \u03b2-thalassemia","volume":"137","author":"Gong","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103513_bib0077","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MOH.0000000000000030","article-title":"Translational control by heme-regulated eIF2\u03b1 kinase during erythropoiesis","volume":"21","author":"Chen","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.retram.2025.103513_bib0078","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.aao0932","article-title":"Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells","volume":"361","author":"Grevet","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.retram.2025.103513_bib0079","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood.2020010020","article-title":"Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo","volume":"138","author":"Psatha","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103513_bib0080","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2217\/pgs-2017-0019","article-title":"An enhancer haplotype may influence BCL11A expression levels and the response to hydroxyurea in \u03b2-thalassemia patie","volume":"18","author":"Maroofi","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.retram.2025.103513_bib0081","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ng.637","article-title":"KLF1 regulates BCL11A expression and \u03b3- to \u03b2-globin gene switching","volume":"42","author":"Zhou","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.retram.2025.103513_bib0082","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/jgm.2928","article-title":"Genetic disruption of the KLF1 gene to overexpress the \u03b3-globin gene using the CRISPR\/Cas9 system","volume":"18","author":"Shariati","year":"2016","journal-title":"J Gene Med"},{"key":"10.1016\/j.retram.2025.103513_bib0083","doi-asserted-by":"crossref","first-page":"9357","DOI":"10.1002\/jcb.27253","article-title":"Disruption of SOX6 gene using CRISPR\/Cas9 technology for gamma-globin reactivation: an approach towards gene therapy of \u03b2-thalassemia","volume":"119","author":"Shariati","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.retram.2025.103513_bib0084","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 variants with undetectable genome-wide off-targets","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.retram.2025.103513_bib0085","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/jcm10030482","article-title":"Genome editing for \u03b2-hemoglobinopathies: advances and challenges","volume":"10","author":"Frati","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.retram.2025.103513_bib0086","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.retram.2025.103513_bib0087","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1249275","article-title":"Genome editing for sickle cell disease: still time to correct?","volume":"11","author":"Ceglie","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.retram.2025.103513_bib0088","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.retram.2025.103513_bib0089","doi-asserted-by":"crossref","first-page":"10576","DOI":"10.1093\/nar\/gkaa764","article-title":"Unbiased investigation of specificities of prime editing systems in human cells","volume":"48","author":"Kim","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.retram.2025.103513_bib0090","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","article-title":"Enhanced prime editing systems by manipulating cellular determinants of editing outcomes","volume":"184","author":"Chen","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.retram.2025.103513_bib0091","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41587-021-01039-7","article-title":"Engineered pegRNAs improve prime editing efficiency","volume":"40","author":"Nelson","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.retram.2025.103513_bib0092","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2023.1148650","article-title":"Prime editing in hematopoietic stem cells\u2014From ex vivo to in vivo CRISPR-based treatment of blood disorders","volume":"5","author":"Wolff","year":"2023","journal-title":"Front Genome Ed"},{"key":"10.1016\/j.retram.2025.103513_bib0093","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.895713","article-title":"Viral vectors for the in vivo delivery of CRISPR components: advances and challenges","volume":"10","author":"Asmamaw Mengstie","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.retram.2025.103513_bib0094","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv"},{"key":"10.1016\/j.retram.2025.103513_bib0095","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acs.accounts.9b00106","article-title":"Delivery aspects of CRISPR\/Cas for in vivo genome editing","volume":"52","author":"Wilbie","year":"2019","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.retram.2025.103513_bib0096","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1369682","article-title":"Era of Genomic Medicine: a narrative review on CRISPR technology as a potential therapeutic tool for Human diseases","volume":"2019","author":"Kotagama","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.retram.2025.103513_bib0097","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3906\/biy-1912-52","article-title":"Bioethical issues in genome editing by CRISPR-Cas9 technology","volume":"44","author":"Ayano\u011flu","year":"2020","journal-title":"Turk J Biol"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:34:13Z","timestamp":1762626853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318625000224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2452318625000224"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2025.103513","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic promise of CRISPR-Cas9 gene editing in sickle cell disease and \u03b2-thalassemia: A current review","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2025.103513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103513"}}